Drugmaker Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Travoprost Ophthalmic Solution ...
Alembic Pharmaceuticals Ltd on Thursday said it has received final approval from the US health regulator for its generic version of Loteprednol Etabonate and Tobramycin ophthalmic suspension used for ...
Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...
International consultancy Accenture announced last week that it had invested in AI startup Alembic, kickstarting a partnership that will leverage the technology to better measure the effectiveness of ...
Enterprises need data, and data needs to be stored, with a flexible, portable environment that scales from developers’ laptops to global clouds. That storage also needs to be able to run on any OS and ...
NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)-- Accenture (ACN) has invested, through Accenture Ventures, in Alembic, a leading AI-powered causal marketing intelligence platform that can determine which ...
Accenture (NYSE: ACN) has invested, through Accenture Ventures, in Alembic, a leading AI-powered causal marketing intelligence platform that can determine which marketing campaigns deliver a return on ...
Led by Prysm Capital and Accenture with participation from Silver Lake Waterman, Liquid 2 Ventures, NextEquity, Friends & Family Capital, and WndrCo, this round positions Alembic among the top AI labs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback